Prevention and treatment of early-stage non-small-cell lung cancer: the Value-Based Healthcare approach to address social disparities

References

• Fitzmaurice C, Abate D, Abbasi N et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 5(12), 1749–1768 (2019).
   PubMed Web of Science ®Google Scholar
• Baek S, He Y, Allen BG et al. Deep segmentation networks predict survival of non-small-cell lung cancer. Sci Rep. 9(1), 1–10 (2019).
   PubMedGoogle Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J. Clin. 70(1), 7–30 (2020).
   PubMed Web of Science ®Google Scholar
• Gorini A, Riva S, Marzorati C, Cropley M, Pravettoni G. Rumination in breast and lung cancer patients: preliminary data within an Italian sample. Psychooncology 27(2), 703–705 (2018).
   PubMed Web of Science ®Google Scholar
• Lucchiari C, Masiero M, Veronesi G et al. Benefits of E-cigarettes among heavy smokers undergoing a lung cancer screening program: randomized controlled trial protocol. JMIR Res Protoc. 5(1), e21 (2016).
   PubMedGoogle Scholar
• Marzorati C, Mazzocco K, Monzani D et al. One-year quality of life trends in early-stage lung cancer patients after lobectomy. Front.Psychol. 11, 534428 (2020).
   PubMed Web of Science ®Google Scholar
• Morrison EJ, Novotny PJ, Sloan JA et al. Emotional problems, quality of life, and symptom burden in patients with lung cancer. Clin. Lung Cancer 18(5), 497–503 (2017).
   PubMed Web of Science ®Google Scholar
• De Koning HJ, Van der Aalst CM, De Jong PA et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N. Engl. J. Med. 382(6), 503–513 (2020).
   PubMed Web of Science ®Google Scholar
• Schabath MB, Cote ML. Cancer progress and priorities: lung cancer. Cancer Epidemiol. Biomark. Prevent. 28(10), 1563 (2019).
   PubMed Web of Science ®Google Scholar
• Patricia Rivera M, Aldrich MC, Henderson LM et al. Addressing disparities in lung cancer screening eligibility and healthcare access. An official American Thoracic Society statement. Am. J. Respir. Crit. Care Med. 202(7), E95–E112 (2020).
   PubMed Web of Science ®Google Scholar
• Hazell SZ, Fu W, Hu C et al. Financial toxicity in lung cancer: an assessment of magnitude, perception, and impact on quality of life. Ann. Oncol. 31(1), 96–102 (2020).
   PubMed Web of Science ®Google Scholar
• Ebner PJ, Ding L, Kim AW et al. The effect of socioeconomic status on treatment and mortality in non-small-cell lung cancer patients. Ann. Thorac. Surg. 109(1), 225–232 (2020).
   PubMed Web of Science ®Google Scholar
• Castro S, Sosa E, Lozano V et al. The impact of income and education on lung cancer screening utilization, eligibility, and outcomes: a narrative review of socioeconomic disparities in lung cancer screening. J Thorac Dis. 13(6), 3757 (2021).
   Web of Science ®Google Scholar
• Elliott I, Gonzalez C, Backhus L, Lui N. Social disparities in lung cancer. Thorac. Surg. Clin. 32(1), 33–42 (2022).
   PubMed Web of Science ®Google Scholar
• Johnson AM, Hines RB, Johnson JA, Bayakly AR. Treatment and survival disparities in lung cancer: the effect of social environment and place of residence. Lung Cancer. 83(3), 401–407 (2014).
   PubMed Web of Science ®Google Scholar
• Ryan BM. Lung cancer health disparities. Carcinogenesis 39(6), 741–751 (2018).
   PubMed Web of Science ®Google Scholar
• Minerva EM, Tessitore A, Cafarotti S, Patella M. Urban-rural disparities in the lung cancer surgical treatment pathway: the paradox of a rich, small region. Front. Surg. 9, 884048 (2022).
   PubMed Web of Science ®Google Scholar
• Shankar A, Dubey A, Saini D et al. Environmental and occupational determinants of lung cancer. Transl. Lung Cancer Res. 8(Suppl. 1), S49 (2019).
   Google Scholar
• Niu X, Roche LM, Pawlish KS, Henry KA. Cancer survival disparities by health insurance status. Cancer Med. 2(3), 403–411 (2013).
   PubMed Web of Science ®Google Scholar
• Sayani A, Vahabi M, O'Brien MA et al. Advancing health equity in cancer care: the lived experiences of poverty and access to lung cancer screening. PLOS ONE 16(5), e0251264 (2021).
   PubMed Web of Science ®Google Scholar
• Porter ME. Value-Based Health Care Delivery. Transac. Meet. Am. Surg. Assoc. 126(4), 144–150 (2008).
   Google Scholar
• Porter ME, Teisberg EO. Redefining Health Care: Creating Value-Based Competition on Results. Harvard Business Press, Boston, MA (2006).
   Google Scholar
• Lucchiari C, Masiero M, Pravettoni G, Vago G, Wears RL. End-of-life decision-making: a descriptive study on the decisional attitudes of Italian physicians. Life Span Disability XIII. 1, 71–86 (2010).
   Google Scholar
• Munzone E, Bagnardi V, Campennì G et al. Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines. Br. J. Cancer 121(4), 325–331 (2019).
   PubMed Web of Science ®Google Scholar
• Porter ME, Larsson S, Lee TH. Standardizing patient outcomes measurement. N. Engl. J. Med. 374(6), 504–506 (2016).
   PubMed Web of Science ®Google Scholar
• Porter ME. Value-Based Health care delivery. Annals of surgery 248(4), 503–509 (2008).
   PubMed Web of Science ®Google Scholar
• Porter ME. What is value in health care?. N. Engl. J. Med. 363(26), 2477–2481 (2010).
   PubMed Web of Science ®Google Scholar
• Josfeld L, Keinki C, Pammer C, Zomorodbakhsch B, Hübner J. Cancer patients' perspective on shared decision-making and decision aids in oncology. J. Cancer Res. Clin. Oncol. 147(3), 1725–1732 (2021).
   PubMedGoogle Scholar
• Marzorati C, Pravettoni G. Value as the key concept in the health care system: how it has influenced medical practice and clinical decision-making processes. J. Multidiscip. Healthc. 10, 101–106 (2017).
   PubMed Web of Science ®Google Scholar
• Gorini A, Masiero M, Pravettoni G. Patient decision aids for prevention and treatment of cancer diseases: are they really personalised tools? Eur. J. Cancer Care 25, 936–960 (2016).
   PubMed Web of Science ®Google Scholar
• Kim JY, Farmer P, Porter ME. Health Policy 1060. 382(9897) 1060–1069 (2013).
   Google Scholar
• Putera I. Redefining health: implication for value-based healthcare reform. 9, e1047 (2017).
   Google Scholar
• Mathew A, Benny SJ, Boby JM, Sirohi B. Value-based care in systemic therapy: the way forward. Curr. Oncol. 29(8), 5792–5799 (2022).
   PubMed Web of Science ®Google Scholar
• Evans N, Grenda T, Alvarez NH, Okusanya OT. Narrative review of socioeconomic and racial disparities in the treatment of early stage lung cancer. J. Thorac. Dis. 13(6), 3758 (2021).
   PubMed Web of Science ®Google Scholar
• Lee VS, Kawamoto K, Hess R et al. Implementation of a value-driven outcomes program to identify high variability in clinical costs and outcomes and association with reduced cost and improved quality. JAMA 316(10), 1061–1072 (2016).
   PubMed Web of Science ®Google Scholar